4
Changes in Ownership
Polaryx Therapeutics, Inc. Filed Acc 0001213900-26-018845
Chief Financial Officer bought 2,867 shares at $2.79 ($7,991)
From the SEC's structured data for this filing
Trades in this filing
Landis G. Michael · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-18 | Purchase : show line 1 in the form | +2,867 | $2.79 | $7,991 | 228,225 | D |
| Open-market purchases · 2,867 sh · avg $2.79 · $7,991 | ||||||
Loading xslF345X05/ownership.xml…